Seminars in Oncology
Volume 29, Issue 6 , Pages 546-551, December 2002

Complementary and alternative medicine research: A National Cancer Institute perspective☆☆

Office of Cancer Complementary and Alternative Medicine, and the Office of Deputy Director of Extramural Science, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Abstract 

The widespread use of a variety of nutritional, psychological and natural medical approaches, collectively termed complementary and alternative medicine (CAM), has been well documented. Recent surveys demonstrate that between 9% and 91% of US cancer patients use CAM therapies at some time after their diagnosis. Despite their extensive use, there is a paucity of data available to indicate whether these practices are efficacious and safe. The National Cancer Institute (NCI) is implementing programs to increase the amount and quality of cancer CAM research, support the production of high-quality CAM cancer information, and facilitate the dialog between CAM practitioners and cancer researchers. Semin Oncol 29:546-551. This is a US government work. There are no restrictions on its use.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Address reprint requests to Jeffrey D. White, MD, Office of Cancer Complementary and Alternative Medicine, National Cancer Institute, Executive Plaza North, Suite 102, Bethesda, MD 20892.

☆☆ This is a US government work. There are no restrictions on its use.

PII: S0093-7754(02)50317-1

doi:10.1053/sonc.2002.50003

Seminars in Oncology
Volume 29, Issue 6 , Pages 546-551, December 2002